Ascendis Pharma A ASND
NASDAQ ASND
$242.99 +4.09 (+1.71%)
At close: Oct 22, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Capital Leases (2012)

Updated

Analysis

Ascendis Pharma A (ASND) Capital Leases (2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Ascendis Pharma A 14.69 Bn 10.95 Bn 362.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 280,426.99
API Access

Ascendis Pharma A Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=ASND&period=max&api_key=YOUR_API_KEY